Chronic Kidney Disease Market: 81M CKD Cases by 2022 Says a New …Watch List News (press release)When the kidneys fail in the advanced stages of CKD, patients are advised to undergo renal replacement therapy (RRT), which includes renal dialysis and ki…
Hamad medical corporation performs third successful spousal kidney transplant – Al-Bawaba
|
Hamad medical corporation performs third successful spousal kidney transplant
Al-Bawaba “We encourage all our patients on the waiting list for kidney transplantation to look for donors among their relatives, as this is not only safe but is also faster than waiting for a deceased donation. We have an excellent transplant record with zero … |
Novartis heart failure drug effective across patient groups – Reuters India
|
Novartis heart failure drug effective across patient groups
Reuters India AMSTERDAM (Reuters) – An experimental drug from Novartis to treat heart failure proved equally effective regardless of the age of patients or whether they had other medical problems, clinical trial results presented on Monday showed. The drug … Novartis heart failure drug found to be effective across patient groupsGlobal Times Novartis’ serelaxin (RLX030) improved symptoms and mortality across multiple …ITNews Novartis: RLX030 Improved Symptoms, Mortality In Heart PatientsNASDAQ |
Chronic Kidney Disease Market: 81M CKD Cases by 2022 Says a New … – PR Web (press release)
Chronic Kidney Disease Market: 81M CKD Cases by 2022 Says a New …PR Web (press release)Chronic kidney disease (CKD), or chronic renal disease, is an asymptomatic, long-term condition that damages the kidneys and leads to the loss of kidney function o…
Novartis heart failure drug effective across patient groups – Reuters UK
|
Novartis heart failure drug effective across patient groups
Reuters UK AMSTERDAM (Reuters) – An experimental drug from Novartis to treat heart failure proved equally effective regardless of the age of patients or whether they had other medical problems, clinical trial results presented on Monday showed. The drug … Novartis’ serelaxin (RLX030) improved symptoms and mortality across multiple …ITNews Novartis: RLX030 Improved Symptoms, Mortality In Heart PatientsNASDAQ Novartis: RLX030 Found Effective Across Multiple Subgroups Of Heart PatientsRTT News |
Novartis heart failure drug effective across patient groups – Reuters
Business Recorder |
Novartis heart failure drug effective across patient groups
Reuters Serelaxin works across sub-groups, study results show. * Heart failure drug viewed as potential blockbuster. By Ben Hirschler. AMSTERDAM, Sept 2 (Reuters) – An experimental drug from Novartis to treat heart failure proved equally effective regardless … More data backs Novartis’ serelaxin in heart failurePMLiVE |
Imdaad organizes blood donation drive – Construction Week Online
Construction Week OnlineImdaad organizes blood donation driveConstruction Week OnlineImdaad showcased another instance of its corporate social responsibility (CSR) programme by organizing a two-day blood donation campaign in August at the company headq…
Rituximab vergoed bij verder onbehandelbare lupus nefritis – NierNieuws.nl
|
Rituximab vergoed bij verder onbehandelbare lupus nefritis
NierNieuws.nl Patiënten met nierontstekingen bij Lupus die niet reageren op de standaardbehandeling, kunnen voortaan via een speciale regeling een behandeling met rituximab vergoed krijgen. Daarvoor moeten de beroepsgroepen van behandelaars wel een register … |
East Ham miracle baby who survived heart attack and multiple organ failure … – Newham Recorder
Newham RecorderEast Ham miracle baby who survived heart attack and multiple organ failure …Newham RecorderAn artificial heart beats inside Zikora Wright to sustain his tiny body after he suffered a cardiac arrest and multiple organ failure before he …
Woodbridge: Lexia wins PR contract for Order of St John organ donor scheme – East Anglian Daily Times
|
Woodbridge: Lexia wins PR contract for Order of St John organ donor scheme
East Anglian Daily Times Further ceremonies will be held in October and November to recognise the 1,212 deceased donors whose families made the brave decision to donate organs last year. Deborah Watson, managing director of Lexia, said: “I feel … “We have previously worked … |